Overview

The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis

Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Patients will be assigned to receive either Depo Medrol or Acthar treatment. A synovial biopsy, blood draws, synovial fluid aspiration, and physician assessments will be performed before and after initiating treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Attune Health Research, Inc.
Collaborator:
Mallinckrodt
Treatments:
Adrenocorticotropic Hormone
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate